This September, we helped our client, the Pulmonary Fibrosis Foundation (PFF), raise awareness about Interstitial Lung Disease (ILD) during the second annual ILD Day. The event was held on Sept. 14 in collaboration with eight other healthcare organizations.
There are more than 200 types of interstitial lung diseases, which all affect the interstitium, a part of the lung. With ILD, inflammation and scarring injure the lungs, making it difficult to breathe and get oxygen to the bloodstream. The damage caused by ILD can be irreversible and worsen over time. Nearly 50,000 new cases are diagnosed in the United States every year. Pulmonary fibrosis (PF) can be seen in many types of ILD.
Common symptoms of ILD include shortness of breath, a dry persistent cough, fatigue and unexplained weight loss. Patients with some diseases, such as rheumatoid arthritis, scleroderma, myositis, dermatomyositis and polymyositis (DM and PM), sarcoidosis and Sjögren’s, are at higher risk for an ILD.
Media coverage of the event included stories on HCPLive, Healio and touchRESPIRATORY. Social media content, blogs and enewsletters also reached audiences directly, and an educational webinar educated at-risk patients about ILD.
The event generated 22 million total impressions and expanded valuable conversations about the signs and symptoms of ILD among patients and health care providers (HCPs). Most notably, website traffic to ildday.org grew significantly. We are proud of the results from the ILD Day campaign, and look forward to even more success in 2023. To learn more about the PFF and ILD, visit pulmonaryfibrosis.org.